In vitro studies in PBMCs of HAM/TSP patients and HTLV-1 carriers have indicated that drugs targeting TNF-α resulted in concomitant lowering of IFN-γ [69], implying that a common mechanism, at least in part, regulates the two cytokines. This evidence concerns the gene IFNG and tropical spastic paraparesis.